Search Results - "Mileshkin L"

Pragmatic gynecologic cancer clinical trials: statements and roadmap from the Gynecologic Cancer InterGroup Chicago Brainstorming Meeting.

Authors: Madariaga A Veneziani A Bookman M et al.

Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Sep; Vol. 36 (9), pp. 104827. Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

Unravelling mutational signatures with plasma circulating tumour DNA.

Authors: Hollizeck S Wang N Wong SQ et al.

Source: Nature communications [Nat Commun] 2024 Nov 14; Vol. 15 (1), pp. 9876. Date of Electronic Publication: 2024 Nov 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Authors: Rebello RJ Posner A Dong R et al.

Source: Nature communications [Nat Commun] 2025 May 20; Vol. 16 (1), pp. 4422. Date of Electronic Publication: 2025 May 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial.

Authors: Lorusso D Gladieff L O'Malley DM et al.

Source: Lancet (London, England) [Lancet] 2026 Apr 18; Vol. 407 (10538), pp. 1513-1524. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin.

Authors: Ugalde A Tothill RW Quinn S et al.

Source: BMC cancer [BMC Cancer] 2025 Jan 29; Vol. 25 (1), pp. 171. Date of Electronic Publication: 2025 Jan 29.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

Authors: Shahnam A Hitchen N Manoharan S et al.

Source: Journal of geriatric oncology [J Geriatr Oncol] 2025 Nov; Vol. 16 (8), pp. 102721. Date of Electronic Publication: 2025 Sep 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial.

Authors: Post CCB de Boer SM Powell ME et al.

Source: The Lancet. Oncology [Lancet Oncol] 2025 Oct; Vol. 26 (10), pp. 1370-1381. Date of Electronic Publication: 2025 Sep 05.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.

Authors: Olawaiye AB Gladieff L O'Malley DM et al.

Source: Lancet (London, England) [Lancet] 2025 Jun 21; Vol. 405 (10496), pp. 2205-2216. Date of Electronic Publication: 2025 Jun 02.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma.

Authors: Obermair A Gebski V Goh J et al.

Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2025 Apr; Vol. 35 (4), pp. 101644. Date of Electronic Publication: 2025 Jan 16.

Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.

Authors: Posner A Prall OW Sivakumaran T et al.

Source: The Journal of pathology [J Pathol] 2023 Jan; Vol. 259 (1), pp. 81-92. Date of Electronic Publication: 2022 Nov 30.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.

Authors: Le Tourneau C André F Helland Å et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113278. Date of Electronic Publication: 2023 Aug 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

The feasibility of triggers for the integration of Standardised, Early Palliative (STEP) Care in advanced cancer: A phase II trial.

Authors: Collins A Sundararajan V Le B et al.

Source: Frontiers in oncology [Front Oncol] 2022 Sep 15; Vol. 12, pp. 991843. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

Authors: Creutzberg CL Kim JW Eminowicz G et al.

Corporate Authors: Creutzberg CL Kim JW Eminowicz G et al.

Source: The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. e420-e431.

Publication Type: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.

Authors: Posner A Sivakumaran T Pattison A et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study.

Authors: Krämer A Bochtler T Pauli C et al.

Source: Lancet (London, England) [Lancet] 2024 Aug 10; Vol. 404 (10452), pp. 527-539. Date of Electronic Publication: 2024 Jul 31.

Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Authors: Pauli C Bochtler T Mileshkin L et al.

Source: The oncologist [Oncologist] 2021 May; Vol. 26 (5), pp. e769-e779. Date of Electronic Publication: 2021 Mar 25.

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.

Authors: Werner B Sjoquist KM Espinoza D et al.

Source: Translational oncology [Transl Oncol] 2024 May; Vol. 43, pp. 101914. Date of Electronic Publication: 2024 Feb 27.

Publication Type: Journal Article

Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

Authors: Westphalen CB Federer-Gsponer J Pauli C et al.

Source: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102035. Date of Electronic Publication: 2023 Nov 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

A systematic review of the impact of contemporary treatment modalities for cervical cancer on women's self-reported health-related quality of life.

Authors: Wiltink LM King M Müller F et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Oct; Vol. 28 (10), pp. 4627-4644. Date of Electronic Publication: 2020 Jun 18.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Authors: Krämer A Bochtler T Pauli C et al.

Corporate Authors: Krämer A Bochtler T Pauli C et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Mar; Vol. 34 (3), pp. 228-246. Date of Electronic Publication: 2022 Dec 20.

Publication Type: Practice Guideline; Research Support, Non-U.S. Gov't; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE